期刊文献+

辛二酰苯胺异羟肟酸对人肝癌SMMC-7721细胞增殖和凋亡的影响 被引量:1

Effects of suberoylanilide hydroxamic acid on proliferation and apoptosis of human hepatocellular carci-noma cell line SMMC-7721 cells
下载PDF
导出
摘要 目的:探讨辛二酰苯胺异羟肟酸(SAHA)对人肝癌细胞株SMMC-7721细胞增殖和凋亡的影响。方法体外培养SMMC-7721细胞,给予不同浓度(2.5、5.0和7.5μmol/L)SAHA处理12~72h,采用噻唑蓝(MTT)比色法检测细胞增殖;加入SAHA(5.0和7.5μmol/L)处理SMMC-7721细胞24h或48h,使用流式细胞仪检测细胞凋亡和细胞周期的变化;采用RT-PCR法检测p53、bcl-2及bax基因mRNA水平;采用分光光度法检测Caspase-3蛋白表达。结果经5.0μmol/L SAHA处理细胞24h和48h时,细胞增殖率较对照下降了25.8%和28.8%,经7.5μmol/L SAHA处理细胞24h和48h时,下降了30.6%和48.6%;经5.0μmol/L或7.5μmol/L SAHA处理细胞24 h后,S期细胞从对照水平(24.33±0.17)%分别显著上升至(32.08±0.160)%和(33.96±0.20)%,(P=0.00),早期凋亡率均由(0.19±0.04)%显著上升至(1.67±0.59)%和(8.92±0.94)%,(P=0.03),而在48h后,S期细胞由(24.33±1.18)%分别显著上升至(32.25±0.53)%和(34.61±0.08)%,早期凋亡率由(0.19±0.04)%分别显著上升至(14.49±2.26)%和(26.23±0.55)%,(P=0.00);SAHA能够上调p53、bax基因mRNA水平,下调bcl-2基因mRNA水平;经5.0μmol/L和7.5μmol/L SAHA处理细胞24h后,Caspase-3蛋白活性由对照水平(0.41±0.07)分别上升至(0.81±0.02),(P=0.01)和(1.09±0.21),(P=0.00),而在处理48 h后,Caspase-3蛋白活性由对照水平分别上升至(1.43±0.23)和(2.01±0.01),(P均=0.00)。结论 SAHA通过影响p53、bcl-2及bax凋亡相关基因水平及Caspase-3蛋白的活性,对人肝癌细胞株SMMC-7721细胞具有抑制增殖和促进凋亡的作用。 Objective To investigate the effects of suberoylanilide hydroxamic acid (SAHA)on the prolifera-tion and apoptosis of human hepatocellular carcinoma (HCC)cell line SMMC-7721 cells. Methods SMMC-7721 cells cultured in vitro were subjected to different concentrations of SAHA(2.5,5.0 and 7.5μmol/L)for 12 to 72h, and cell viability was determined by MTT assay;SMMC-7721 cells were incubated with SAHA (5.0 and 7.5μmol/L)for 24 or 48 hours,and flow cytometry was used to detect cell apoptosis and cell cycle turnover;RT-PCR was used to detect the mRNA levels of p53,bcl-2 and bax,while caspase-3 activity was detected by spectropho-tometric. Results After 24 or 48 hours of incubation with SAHA at concentration of 5.0μmol/L,the prolifera-tion of SMMC-7721 cells decreased by 25.8% and 28.8%,respectively,and with SAHA at 7.0μmol/L decreased by 30.6% and 48.6%,respectively;After 24 hours of incubation with SAHA at 5.0 and 7.5μmol/L,the percentage of cells in S-stage increased from the control level of(24.33±0.17)% to(32.08±0.160)% and (33.96±0.20)%,re-spectively(P=0.00),and the apoptosis rate increased from (0.19±0.04) to (1.67±0.59) and (8.92±0.94),respec-tively,P=0.03),while after 48 hours of incubation,cells in S-stage increased from(24.33±1.18)%to(32.25±0.53) and (34.61±0.08)%,respectively,and the apoptosis rate increased from (0.19±0.04) to (14.49±2.26) and(26.23±0.55),(P=0.00),respectively (P=0.03);SAHA increased the p53 and bax mRNA and reduced the bcl-2 mRNA levels;After incubation with SAHA at 5.0μmol/L and 7.5μmol/L for 24h,the caspase-3 activity increased from the control level of(0.41±0.07)to(0.81±0.02),(P=0.01)and(1.09±0.21),(P=0.00),respectively,while after 48 hours,the caspase-3 activity increased from (0.41±0.07)to(1.43±0.23) and (2.01±0.01),respectively(P=0.00). Conclusions SAHA inhibits proliferation of and induces apoptosis in SMMC-7721 cells,and this effect is associ-ated with an impact on the apoptosis-related gene of p53,bcl-2 and bax and caspase-3 pathway.
出处 《实用肝脏病杂志》 CAS 2013年第6期532-535,共4页 Journal of Practical Hepatology
基金 大连市医学卫生科学研究计划项目(编号:2013192)
关键词 肝癌 辛二酰苯胺异羟肟酸 细胞凋亡 细胞周期 CASPASE-3 CASPASE-3 Hepatocellular carcinoma Suberoylanilide hydroxamic acid Apoptosis Cell cycle
  • 相关文献

参考文献4

二级参考文献27

  • 1BURK D. On the significance of glycolysis for cancer growth with special reference to morris rat hepatomas [J]. J Natl Cancer Res, 1967,38:839.
  • 2WEBER G. Behavior of liver enzymes in hepatocarcinogenesis[J]. Adv Cancer Res, 1961,6:403-94.
  • 3HARRISON SA,DI BISCEGLIE AM. A new approach to therapy for hepatocellular carcinoma[J]. Hepatology,2003,37 (2):471-473.
  • 4KO YH,PEDERSEN PL,GESCHWIND JE Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase [J]. Cancer Lett, 2001,173( 1 ) : 83-91.
  • 5WARBURG O. On the origin of cancer cells [J]. Science, 1956,123(3191 ) :309-314.
  • 6BUSTAMANTE E,MORRIS HP,PEDERSEN PL. Energy metabolism of tumor cell. Requirement for a form of hexokinase with a propensity for mitochondrial binding[J]. J Biol Chem, 1981,256(16) : 8699-8704.
  • 7REMPEL A,MATHUPALA SP,GRIFFIN CA,et al. Glucose catabolism in cancer cells:amplification of the gene encoding type II hexokinase [J]. Cancer Res, 1996,56(11 ) : 2468-2471.
  • 8KO YH,MCFADDEN BA. Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate[J]. Arch Biochem Biophys, 1990,278(2) : 373-380.
  • 9NELSON K. 3-Bromopyruvate kills cancer cells in animals [J]. Lancet Oncol,2002,3(9) :524.
  • 10GWAK GY,YOON JH,KIM KM,et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase Ⅱ expression[J]. J Hepatol,2005, 42(3) :358-364.

共引文献5

同被引文献8

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部